Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Palantir Technologies is trading at $208.67, up 8.6% on the week, but the options market is quietly flashing the most defensive reading of the past year as Q3 results approach.
Options positioning is the sharpest signal in the data right now. The put/call ratio has jumped to 1.13, nearly three standard deviations above its 20-day average of 1.06, putting it near the 52-week high of 1.16. That is not a panicked reading, but it is notably elevated for a stock that just added 25% in a month. Traders are buying protection into the November 2 earnings date even as the price keeps climbing. The borrow market tells a different story: availability remains effectively unlimited, with over two billion shares available to lend and cost to borrow at just 0.41%, even after a 35% week-on-week rise in that rate. Short interest has fallen 15% over the past month to 2.5% of free float. There is no squeeze pressure here and no meaningful short thesis with borrow this cheap and availability this wide.
The Street has been moving decisively in one direction. Goldman Sachs upgraded to Buy last week with a $230 target. Barclays initiated at Overweight with a $265 target the following day. Those two actions, both within the past five trading days, represent the most concentrated bullish analyst activity in this cycle. UBS carries a $250 target, Citigroup $245, and DA Davidson $250. The formal consensus still reads "hold" with a mean target of $185, but that aggregate is heavily skewed by the ten analysts who have not updated their views since well before the Q2 print. The active coverage sits $20 to $55 above the current price. The tension is in the valuation: the PE multiple has expanded to 95x, up 13 points over the past month, and EV/EBITDA is at 69x. EPS momentum scores rank in the 83rd to 87th percentile, and EPS surprise in the 77th, which goes some way to justifying the premium. The forward EPS growth score, at just the 14th percentile, is where the bear case lives. Bulls point to 110% year-on-year commercial revenue growth in Q2 and 186% net revenue retention as evidence of durable expansion. Bears flag the reliance on a small number of large government contracts and competition from Microsoft, Amazon, and Oracle in the commercial AI space.
Insider activity over the past 90 days adds context rather than alarm. Net selling over that period totals roughly $105 million, but every recent open-market transaction on the register was executed under a pre-arranged 10b5-1 plan. Director Lauren Friedman sold $1 million of stock on October 8 under such a plan. Ryan Taylor sold $3.6 million the same day, also under a plan. Scheduled sales are not conviction signals. The September 29 awards to Taylor and CFO David Glazer, each receiving over 92,000 shares through grant transactions, are routine compensation mechanics. On the institutional side, BlackRock holds 7.9% and State Street added nearly 2.9 million shares in its most recent reporting period. JP Morgan Asset Management added 7.8 million shares through September 30. The buying among passive and semi-active institutions reflects index-weight mechanics as the stock's market cap has grown, not a fresh discretionary call.
The earnings history underscores why positioning matters here. The Q2 print on August 3 produced a 32% single-day move and a 42% gain over the following five sessions. That is the only recent print in the data, but its scale sets a high bar for what the market has already absorbed. The stock is now more than 66% above that print. The next event is November 2, 19 days away, and the options market is already pricing in meaningful uncertainty even as short sellers have largely stepped aside.
What to watch is whether the gap between the most recent bullish analyst targets, which cluster between $230 and $265, and the current $208 price narrows or widens as the November 2 date approaches, and whether the put/call ratio, already near its 52-week high, continues drifting higher as traders add more downside protection ahead of the print.
See the live data behind this article on ORTEX.
Open PLTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.